:-TARTARE-2S

Ville Pettilä1, Carmen A Pfortmüller2, Anders Perner3,4

  • 1Division of Intensive Care Medicine, Department of Perioperative, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Critical care medicine
|October 17, 2025
PubMed
概括

与标准护理相比,针对性组织输液在败血症休克患者的治疗结果没有改善. 这种方法允许降低血压,但在30天的生存日数或死亡率上没有显著差异.